Advanced Renal Cancer Drug to Treat Mesothelioma – Austrian Research
Researchers from Austria have found that Temsirolimus, a kidney cancer drug can treat the cancer of the lungs caused by exposure to the asbestos. The results of their study are published in the May 2011 issue of the Journal of Thoracic Oncology.
The drug was found in the research study to block a protein mTOR associated with the abnormal growth of mesothelioma. The findings prove that this drug can be made more potent by administrating it along with a widely used chemotherapy drug cisplatin or as a second line of treatment option after chemotherapy.
The symptoms of cancer mesothelioma are notorious of remaining latent up to 30-50 years of their onset and do not respond to the standard treatment options of cancer like chemotherapy and radiation therapy.
As a part of further research studies, the experts are commencing clinical trials of mTOR inhibitors as a novel treatment options for mesothelioma cancer. The Medical Scientific Fund of the Mayor of the City of Vienna and Initiative Krebsforschung of the Medical University Vienna supported the study along with a Wyeth/Pfizer research grant.